The role of pharmacokinetic modelling and computer simulation in drug formulation design

被引：4
|
作者：
Grabnar, I
Belic, A
Mrhar, A
Karba, R
机构：
[1] Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia
[2] Univ Ljubljana, Fac Elect Engn, Ljubljana 1000, Slovenia
来源：
COMPUTERS IN BIOLOGY AND MEDICINE | 1998年 / 28卷 / 04期
关键词：
nitrendipine; pharmacokinetics; modelling and simulation; drug formulation design; optimisation of antihypertensive effect;
D O I：
10.1016/S0010-4825(98)00020-1
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
The purpose of this study is to develop a formulation for a once-a-day peroral application with controlled release of nitrendipine. The second aim of the study is to define by the use of modelling and computer simulation those critical points iu the development of the formulation, the knowledge and controlling of which brings a rationalisation in the sense of time and material. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：365 / 376
页数：12
相关论文
共 50 条
  • [1] Exploring clinical study design by computer simulation based on pharmacokinetic/pharmacodynamic modelling
    Gieschke, R
    Reigner, BG
    Steimer, JL
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1997, 35 (10) : 469 - 474
  • [2] Formulation of controlled release microspheres containing nicardipine: the role of pharmacokinetic modeling and computer simulation
    Mrhar, A
    Bogataj, M
    Grabnar, I
    Karba, R
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1999, 24 (01) : 55 - 61
  • [3] Formulation of controlled release microspheres containing nicardipine: the role of pharmacokinetic modeling and computer simulation
    A. Mrhar
    M. Bogataj
    I. Grabnar
    R. Karba
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 1999, 24 : 55 - 61
  • [4] ANALOG COMPUTER IN DRUG DOSAGE AND FORMULATION DESIGN
    GARRETT, ER
    LAMBERT, HJ
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1966, 55 (06) : 626 - &
  • [5] Bioavailability Through PepT1: The Role of Computer Modelling in Intelligent Drug Design
    Foley, David W.
    Rajamanickam, Jeyaganesh
    Bailey, Patrick D.
    Meredith, David
    [J]. CURRENT COMPUTER-AIDED DRUG DESIGN, 2010, 6 (01) : 68 - 78
  • [6] Computer simulation in molecular medicine and drug design
    S. D. Varfolomeev
    S. V. Lushchekina
    A. V. Nemukhin
    [J]. Herald of the Russian Academy of Sciences, 2016, 86 : 185 - 192
  • [7] Computer simulation in molecular medicine and drug design
    Varfolomeev, S. D.
    Lushchekina, S. V.
    Nemukhin, A. V.
    [J]. HERALD OF THE RUSSIAN ACADEMY OF SCIENCES, 2016, 86 (03) : 185 - 192
  • [8] Computer-Assisted Drug Formulation Design: Novel Approach in Drug Delivery
    Metwally, Abdelkader A.
    Hathout, Rania M.
    [J]. MOLECULAR PHARMACEUTICS, 2015, 12 (08) : 2800 - 2810
  • [9] Computer modelling and simulation for the design of integrated downstream bioprocesses
    Zhou, YH
    TitchenerHooker, NJ
    [J]. 1997 JUBILEE RESEARCH EVENT, VOLS 1 AND 2, 1997, : 809 - 812
  • [10] Computer-aided Drug Design and Drug Pharmacokinetic Prediction: A Mini-review
    Tabeshpour, Jamshid
    Sahebkar, Amirhossein
    Zirak, Mohammad Reza
    Zeinali, Majid
    Hashemzaei, Mahmoud
    Rakhshani, Sajed
    Rakhshani, Saleh
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (26) : 3014 - 3019
12345